Narrative review reveals enzyme-responsive drug release and intermittent fiber growth in supramolecular gels, highlighting their utility for targeted intestine delivery.
Supramolecular gels are soft materials formed through the self-assembly of low-molecular-weight gelators via noncovalent interactions. Because their molecular structures can be precisely designed, supramolecular gels are promising functional materials with stimuli-responsive properties. This review summarizes our studies on the design and development of supramolecular gels for pharmaceutical applications, as well as the mechanistic elucidation of supramolecular gelation. First, disaccharide-coupled amphiphilic ureas were designed as low-molecular-weight gelators for small intestine-targeted drug delivery systems. Maltose- and lactose-coupled amphiphilic ureas, Mal-Cn and Lac-Cn, were synthesized in three steps. The resulting supramolecular gels showed enzymatic hydrolysis-responsive phase transitions triggered by disaccharidases. In particular, the supramolecular gel formed from Lac-C8 was degraded by β-galactosidase, and the entrapped model drug, Rhodamine 6G, was released as the gel degraded. These results demonstrate the potential of enzymatic hydrolysis-responsive supramolecular gels as drug carriers. Second, the gelation mechanism of a urea-based low-molecular-weight gelator was investigated using high-speed atomic force microscopy. Direct observation revealed that gel-forming fibers grew through repeated elongation and pause phases. A block-stacking model was proposed to explain the intermittent growth of fibers. Through these observations and additional experimental analyses, we elucidated the mechanism of supramolecular gelation.
No takes yet. Share an insight, caveat, or question.
Shinya Kimura (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: